GelTech Labs published a study developed a temperature-responsive liposomal formulation that forms a depot after subcutaneous injection using buprenorphine as a model drug.
Published
Signal category
Research & Knowledge
Quote
“A recent study developed a temperature-responsive liposomal formulation that forms a depot after subcutaneous injection.”
— Taylor Barkdoll|GelTech Labs team
Company
GelTech Labs
Helping labs develop better hydrogels, faster with robotic automation tools.
- Industry
- Biotechnology Research
- Location
- San Diego, US
- Company size
- 13 employees
Revolutionizing hydrogel testing through automation. Hydrogels are next-gen materials enabling breakthroughs in drug delivery, wound care, tissue engineering, cosmetics, contact lenses, and more—yet testing their properties remains largely manual, slow, and error-prone. GelTech’s flagship product, Carousel, is the first automation tool designed specifically for hydrogel swelling and degradation testing—cutting costs, boosting reproducibility, and accelerating innovation across the $5B polymer lab market. Backed by $1M in funding, NSF I-Corps, and partnerships with academic and enterprise leaders, we are setting a new industry standard and paving the way for smarter R&D, Quality Control and faster commercialization of hydrogel-based products.
Founded 2023